Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Cantor Fitzgerald
Mallinckrodt
Healthtrust
Chubb
Accenture
Deloitte
Boehringer Ingelheim
Citi
US Army

Generated: August 21, 2017

DrugPatentWatch Database Preview

Spirapril hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for spirapril hydrochloride and what is the scope of spirapril hydrochloride patent protection?

Spirapril hydrochloride
is the generic ingredient in one branded drug marketed by Schering and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for Generic Name: spirapril hydrochloride

Tradenames:1
Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list21
Clinical Trials: see list2,261
Patent Applications: see list3,910
Drug Prices:see low prices
DailyMed Link:spirapril hydrochloride at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering
RENORMAX
spirapril hydrochloride
TABLET;ORAL020240-001Dec 29, 1994DISCNNoNo► Subscribe► Subscribe► Subscribe
Schering
RENORMAX
spirapril hydrochloride
TABLET;ORAL020240-003Dec 29, 1994DISCNNoNo► Subscribe► Subscribe► Subscribe
Schering
RENORMAX
spirapril hydrochloride
TABLET;ORAL020240-004Dec 29, 1994DISCNNoNo► Subscribe► Subscribe► Subscribe
Schering
RENORMAX
spirapril hydrochloride
TABLET;ORAL020240-002Dec 29, 1994DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: spirapril hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Schering
RENORMAX
spirapril hydrochloride
TABLET;ORAL020240-001Dec 29, 1994► Subscribe► Subscribe
Schering
RENORMAX
spirapril hydrochloride
TABLET;ORAL020240-003Dec 29, 1994► Subscribe► Subscribe
Schering
RENORMAX
spirapril hydrochloride
TABLET;ORAL020240-002Dec 29, 1994► Subscribe► Subscribe
Schering
RENORMAX
spirapril hydrochloride
TABLET;ORAL020240-004Dec 29, 1994► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Express Scripts
Johnson and Johnson
Covington
Mallinckrodt
Fuji
Queensland Health
Teva
Fish and Richardson
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot